版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Leukemia(白血?。?/p>
陳方平白血病Leukemia
TherapyandPrognonisContentsOutlineClassificationClinicalfeaturesDiagnosisAcuteleukemaChronicleukema白血病WhatIsLeukemia?CancerofthewhitebloodcellsAcuteorChronicAffectsabilitytoproducenormalbloodcellsBonemarrowmakesabnormallylargenumberofimmaturewhitebloodcellscalledblasts白血病Definition
AbnormalityofWBCMarrowfailureInfiltrationoftissues
HematopoieticstemcellmalignanciesMalignantproliferationofleukemiccells白血病DevelopmentofLeukemiaintheBloodstreamStage1-NormalStage2-SymptomsStage3-DiagnosisStage4-WorseningStage5a-AnemiaStage5b-InfectionLegendWhiteCellRedCellPlateletBlastGermSourcesfromLeukemia,byD.NewtonandD.Siegel白血病HistoryMeans“whiteblood”inGreekDiscoveredbyDr.AlfredVelpeauinFrance,1827NamedbypathologistRudolfVirchowinGermany,1845白血病ResultsinChina(N/100,000)Morbilityinadults2.01.0
ANLL
ALLCMLCLL1.620.690.360.05Morbility白血病EtiologyVirusRadiationChemicalsInheritanceOtherkindsofhematopoieticdisease白血病ClassificationofleukemiaAcuteChronicMyeloidoriginLymphoidoriginAcuteMyeloidLeukemia(AML)AcuteLymphoblasticLeukemia(ALL)ChronicMyeloidLeukemia(CML)ChronicLymphocyticLeukemia(CLL)白血病HematopoieticStemCellLifespanDecadesYearsMonthsWeeks,DaysRedbloodcellsWhitebloodcellsPlatelets白血病LifespanDecadesYearsMonthsWeeks,DaysRedbloodcellsWhitebloodcellsPlateletsHematopoieticStemCell白血病RedbloodcellsWhitebloodcellsPlateletsHematopoieticStemCell白血病RedbloodcellsWhitebloodcellsPlateletsHematopoieticStemCell白血病AcuteLeukemiaHematopoieticStemCell白血病HematopoieticStemCellChemotherapy白血病HematopoieticStemCellRedbloodcellsWhitebloodcellsPlateletsRemissionResidualleukemiastemcells白血病HematopoieticstemcellNeutrophilsEosinophilsBasophilsMonocytesPlateletsRedcellsMyeloidprogenitorLymphoidprogenitorB-lymphocytesT-lymphocytesPlasmacellsgerminalcenterna?veALLAML白血病differentiationblockenhancedproliferationAcuteLeukemia+Gainoffunctionmutationsoftyrosinekinaseseg.FLT3,c-KITmutationsN-andK-RASmutationsBCR-ABLTEL-PDGFbRLossoffunctionoftranscriptionfactorsneededfordifferentiationeg.AML1-ETOCBFb-SMMHCPML-RARaTwo-hitmodelofleukemogenesis白血病ClassificationofacuteleukemiaALLmainlychildrenM>Fcurablein70%ofchildrencurableinminorityofadultsAMLmainlyadultsM>Fcurableinminorityofadults白血病Clinicalfeatures
(一)MalignantproliferationofleukemiccellsMarrowfailureInfiltrationoftissuesAnemiaFeverBleedingAcuteleukemia白血病Clinicalfeatures
(二)AcuteleukemiaAnemia
(progressive,weakness,pale)Fever(mostlybyinfection)
CommonSevereUncontrolledPathogen:G-、G+、virus、funguset.al白血病Clinicalfeatures
(三)AcuteleukemiaBleeding
Common、progressivelocus:skinandmucous
(purpura、ecchymosis
)
Bleedingofinternalorgans白血病petechiaecchymosispurpura白血病Clinicalfeatures
(三)AcuteleukemiaInfiltrationoftissues/organsLymphnode,enlargementofliverandspleenBonepainCNSL(中樞神經(jīng)系統(tǒng)白血?。?/p>
Mouth、skin、eye(Granulocyticsarcoma
)
Other(testis)白血病Infiltrationoftissues(gum)白血病Infiltrationoftissues(skin)白血病lymphadenopathy白血病Splenomegaly白血病Laboratory(一)Bloodtest
WBC+DC:HyperleukocyticAL(>100×109/L)
Hypoplastic
AL(lowerthannormal)
Blasticcellandjuvenilecells
HB+RBCPtAcuteleukemia白血病PicturesOfBloodNormalhumanbloodWhiteCellRedCellPlateletBloodwithleukemiaBlastsRedCellPlateletWhiteCell白血病Marrowblasticcells≥30%normalbloodcellsreducedhypoplasticleukemiaAuerrods數(shù)的異常質(zhì)的異常AcuteleukemiaLaboratory(二)白血病Siteformarrowsamples白血病MarrowBiopsy:CellularorHypercellularHypocellular白血病
NormalAML
ALL
Auerrods白血病ClassificationofacuteleukemiaMethods1.FAB2.MICM白血病SubclassificationALL
Commontype(pre-B)B-cellT-cellUndifferentiated白血病ALLL1(85%):smaller,highn/cratio,indistinctnucleoli白血病ALLL2(14%):larger,morecytoplasm,pleomorphic,moredistinctnucleoli白血病ALLL3(1%):cytoplasmicbasophilia(Ig),vacuoles(Burkitt’sleukemia)白血病MyelomonoFABofAML白血病AMLFrench-American-British(FAB)ClassificationM0:MinimallydifferentiatedleukemiaM1:MyeloblasticleukemiawithoutmaturationM2:MyeloblasticleukemiawithmaturationM3:HypergranularpromyelocyticleukemiaM4Eo:Variant:IncreaseinabnormalmarroweosinophilsM4:MyelomonocyticleukemiaM5:MonocyticleukemiaM6:Erythroleukemia(DiGuglielmo'sdisease)M7:Megakaryoblasticleukemia白血病形態(tài)學(xué)Morphology免疫學(xué)
Immunology細(xì)胞遺傳學(xué)Cytogenetics分子生物學(xué)MolecularbiologyMICMClassificationofacuteleukemia白血病MPO(right)&Sudanblack(left)showingintenselocalisedpositivityinblasts白血病Laboratory(三)Chemicaldye
L(淋)M(粒)N(單)POX
-++~+++-~+NSE
--~+++~+++NaF
-+
PAS+~++-~++~++Acuteleukemia白血病AcuteleukemiaLaboratory(四)Immunology
ANLL—CD13、CD33、CD14
T-ALL—CD3、CD2、CD7、CD8B-ALL—CD10、CD19、CD22
、HLA-DR
cytogeneticsandmolecularbiology
M3T(15;17)(q22;q21)PML-RARaL1T(9,22)(q34;q11)BCR-ABL
白血病
AcuteleukemiaMethod:twostepsDifferentialdiagnosisAcuteleukemiawithnormalamountofWBCs
①AA②PNH③ITP④recoveryofleukophenia⑤MDS⑥IDAAcuteleukemiawithhigheramountofWBCs①infectiousmonocytosis②leukemoidreaction
Diagnosis白血病TherapyofAL(一)SupportivemedicalcareControllinginfectionAvoidingbleedingandanemiaHematopoieticCellfactorsProtectionofimportantorgans白血病TherapyofAL(二)ChemotherapyPurpose:
firstgoalisCR,furtherRxtopreventrelapse
CR(completeremission)symptomsandsignsdisappearPB:HB≥100g/lN≥1.5×109/lPt≥100×109/lwithnoleukocyteBMBlastcells≤5%Rules:early,complete,combined
intermittent,differentstage白血病
TherapyofAL(三)Chemotherapy3stagesinduction(初治)→consolidation(鞏固強(qiáng)化)→maintenance(維持治療)leukemiccells1010-13106-8104(symptom)(CR)(maintenance)白血病othersRadiotherapy
OnlyforCNSL、TestisleukemiaandBMTHSCTransplantationGeneTherapy
TherapyofAL(三)白血病Hematopoieticstemcelltransplantationpermits“rescue”fromotherwiseexcessivelytoxictreatmentadditionaladvantageofgraft-vs-leukemiaeffectinallogeneictransplantstrade-offforallogeneictransplantation:greateranti-leukemiceffectbutmoretoxic白血病
Factors
Age、amountofWBCs、MDSFAB、cytogeneticAcuteleukemiaprognosis白血病PrognosisAdultAMLAdultALLsimilartoorworsethanAML白血病ClinicalPresentation:Itcanoccurinanyage.Butthemostagepresentationisbetween40-60.Symptomsrelatedtohypermetabolism:(weightloss,lassitude,anorexiaornightsweats).(Goutorrenalimpairmentcausedbyhyperuriceamia).Bonemarrowfailure:Anemia.白血病CML
Ph+vePh–ve,BCR-abl+vePh–ve,BCR-abl-veEosinophilicLeukemia
Ph:PhiladelphiachromosomeBCR:Breakpointclusterregion;abl:AbelsononcogeneChronicmyeloidleukemia白血病Picture4.Bonemarrowfilmat400Xmagnificationdemonstratescleardominanceofgranulopoiesis.Thenumberofeosinophilsandmegakaryocytesisincreased.白血病Philadelphia:Isthechromosomewhichresultfromthet(9;22)(q34;q11)partoftheAbelsonproto-oncogeneABLismovedtotheBCRgeneonchromosome22&partofchromosome22movestochromosome9.Theabn
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 醫(yī)療運(yùn)營(yíng)效率的績(jī)效分配瓶頸突破
- 《GBT 19421-2008層狀結(jié)晶二硅酸鈉試驗(yàn)方法》專(zhuān)題研究報(bào)告深度
- 2025年鄖西縣事業(yè)單位公開(kāi)招聘工作人員備考題庫(kù)及參考答案詳解
- 2026年南方科技大學(xué)公共衛(wèi)生及應(yīng)急管理學(xué)院劉小敏課題組誠(chéng)聘博士后、科研助理和訪(fǎng)問(wèn)學(xué)生備考題庫(kù)有答案詳解
- 2026年國(guó)盛資管社會(huì)招聘?jìng)淇碱}庫(kù)及參考答案詳解一套
- 2026年寧波東方人力資源服務(wù)有限公司(擬派遣到寧波大學(xué))非事業(yè)編制人員招聘?jìng)淇碱}庫(kù)及完整答案詳解一套
- 2026年雙流中學(xué)九江實(shí)驗(yàn)學(xué)校(北區(qū))第一批教師招聘?jìng)淇碱}庫(kù)完整參考答案詳解
- 2026年九江市專(zhuān)業(yè)森林消防支隊(duì)(九江市綜合應(yīng)急救援支隊(duì))招聘10人備考題庫(kù)及一套完整答案詳解
- 2026年中化學(xué)開(kāi)發(fā)建設(shè)有限公司招聘?jìng)淇碱}庫(kù)及參考答案詳解一套
- 2026年四平市中西醫(yī)結(jié)合醫(yī)院招聘護(hù)理人員備考題庫(kù)及參考答案詳解1套
- 集團(tuán)有限公司安全生產(chǎn)責(zé)任清單(全員)
- 陜西能源職業(yè)技術(shù)學(xué)院2026年教師公開(kāi)招聘?jìng)淇碱}庫(kù)及答案詳解(奪冠系列)
- 2026屆全國(guó)新高考語(yǔ)文沖刺復(fù)習(xí):疑問(wèn)的三種情況作文講評(píng)
- 地質(zhì)鉆探施工方案
- 2026年1月上海市春季高考數(shù)學(xué)試題卷(含答案)
- 高壓供電協(xié)議中的合同
- 2026年植物保護(hù)(植物檢疫)考題及答案
- 2025年長(zhǎng)護(hù)險(xiǎn)考試試題及答案
- 11837《行政法與行政訴訟法》國(guó)家開(kāi)放大學(xué)期末題庫(kù)
- 高純水制取工創(chuàng)新應(yīng)用能力考核試卷含答案
- 四川省德陽(yáng)市2026屆高三12月第一次診斷考試數(shù)學(xué)試卷(含答案)
評(píng)論
0/150
提交評(píng)論